---
name: Sygnature Discovery
slug: sygnaturediscovery
site: cro
website_domain: sygnaturediscovery.com
summary: Integrated drug discovery CRO covering target identification through lead optimization, with computational design, structural biology, medicinal chemistry and DMPK support. Serves biotech and pharma clients across the US, Canada, UK and Europe. Headquartered in United Kingdom.
tagline: Integrated drug discovery from target ID to lead optimization
founded_year: 
employee_count_band: 201-1000
employee_count_label: 201–1,000
parent_name: 
parent_slug: 
hq_country: GB
tier2_domain_verified: false
updated_at: 2026-11-04T07:03:48.350Z
services_count: 7
modalities_count: 2
indications_count: 0
locations_count: 2
review_signal_gate: closed
generated_by: BioBM Editorial AI
---

# Sygnature Discovery

Integrated drug discovery from target ID to lead optimization

Listed on cro.directory.

## Summary

Integrated drug discovery CRO covering target identification through lead optimization, with computational design, structural biology, medicinal chemistry and DMPK support. Serves biotech and pharma clients across the US, Canada, UK and Europe. Headquartered in United Kingdom.

## At a glance

- Employees (est.): 201–1,000
- HQ country: GB

## Services

- Target Identification & Validation
- Discovery Research
- Medicinal Chemistry
- Computational & In-Silico Drug Discovery
- Bioinformatics & Data Science
- In Vitro ADME / DMPK
- Preclinical In Vivo Studies

## Modalities

- Small Molecule
- Biologics (Monoclonal Antibodies)

## Locations

- UK site, United Kingdom
- Canada site, Canada

## Long description

## Integrated drug discovery

Sygnature Discovery describes its model as truly integrated drug discovery, with co-located teams moving compounds from target identification to candidate.

- **Target identification and validation:** AI-supported platform combined with expert insight and laboratory validation.
- **Hit identification and hit-to-lead:** validated hits and early proof-of-concept work, de-risked and profiled before lead optimization.
- **Lead optimization:** advancing leads toward clinical candidates.

## Scientific solutions

The site lists capabilities in computer-aided drug design (including structure-based and ligand-based design, virtual screening, ADMET prediction and generative AI/machine learning), protein science and structural biology (including antibodies and biotherapeutics, X-ray crystallography, cryo-EM and NMR), chemistry, drug metabolism and pharmacokinetics, in vivo pharmacology, and form and formulation.

## Scale and reach

The About page states 700+ scientists from over 50 countries and 60+ advanced candidates. The company describes partnering with biotech and pharma across the US, Canada, the UK and Europe, with UK and Canada sites.

## Related companies

- [AAPharmaSyn](/companies/aapharmasyn) (Discovery Research, Medicinal Chemistry) — [Compare](/compare/aapharmasyn/sygnaturediscovery)
- [Selvita](/companies/selvita) (Target Identification & Validation, Discovery Research) — [Compare](/compare/selvita/sygnaturediscovery)
- [Synfini, Inc.](/companies/synfini) (Discovery Research, Medicinal Chemistry) — [Compare](/compare/sygnaturediscovery/synfini)
- [PozeSCAF Inc.](/companies/pozescaf-discovery-solutions) (Target Identification & Validation, Discovery Research) — [Compare](/compare/pozescaf-discovery-solutions/sygnaturediscovery)
- [BioAscent Discovery](/companies/bioascent-discovery) (Target Identification & Validation, Discovery Research) — [Compare](/compare/bioascent-discovery/sygnaturediscovery)
- [Proone Labs](/companies/proonelabs) (Target Identification & Validation, Discovery Research) — [Compare](/compare/proonelabs/sygnaturediscovery)
- [Aurigene Pharmaceutical Services Limited](/companies/aurigeneservices) (Target Identification & Validation, Discovery Research) — [Compare](/compare/aurigeneservices/sygnaturediscovery)
- [Eurofins Discovery](/companies/eurofinsdiscovery) (Target Identification & Validation, Discovery Research) — [Compare](/compare/eurofinsdiscovery/sygnaturediscovery)

_Profile last updated: 2026-11-04T07:03:48.350Z. Profile facts may include AI-assisted enrichment._

Auto-generated by BioBM Editorial AI for machine-readable profile access.